GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,048 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Q1 2025 vs. Q4 2024
How the institutions holding GSK plc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 851 | 14 | 860 | +23 |
| Shares | 341.8M | 194.1K | 366.2M | +24.6M (+7.2%) |
| Value | $11.6B | $6.57M | $14.2B | +$2.62B (+22.6%) |
14 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (91)
Institutions that held GSK plc at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (68)
Institutions that held GSK plc at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (14)
Institutions that held GSK plc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 42,293 | $1.43M |
| Vise Technologies, Inc. | 38,419 | $1.30M |
| Global Retirement Partners, LLC | 36,847 | $1.25M |
| Wetherby Asset Management Inc | 26,447 | $894.4K |
| Northwest Bank & Trust Co | 22,405 | $764.6K |
| Lake Street Advisors Group, LLC | 8,298 | $283.6K |
| Boston Financial Mangement LLC | 8,182 | $276.7K |
| Capstone Triton Financial Group, LLC | 6,996 | $236.6K |
| Hilltop National Bank | 2,291 | $77.5K |
| Wintrust Investments LLC | 645 | $21.0K |
| Sanctuary Wealth Management, L.L.C. | 556 | $18.8K |
| Oliver Lagore Vanvalin Investment Group | 518 | $17.5K |
| Zions Bancorporation, N.A. | 172 | $5.82K |
| RE Dickinson Investment Advisors, LLC | 5 | $200 |